ReachMD

Dr. Tatjana Rundek is an associate professor of neurology and a director of clinical translational research in the division of the department of neurology of the Miller School of Medicine, the University of Miami in Florida, and an adjunct faculty at Columbia University in New York.

Dr. Rundek graduated from University of Zagreb where she received her medical degree. She received a PhD degree in neuroscience, and trained in neurology at the Grossharden Spital in Munich and at the University Hospital Sisters of Mercy in Zagreb, where she was chief resident 1991-2. She received research fellowship training in neuroepidemiology at Columbia University. She was an assistant professor of neurology at the department of neurology at Columbia University and director of the Non-Invasive Vascular Laboratory in neurology until she relocated to the University of Miami in 2007.

Dr. Rundek is a principal investigator of the NIH fundedR01s Genetic determinants of carotid atherosclerosis study, Extreme phenotypes of subclinical atherosclerosis and the K24 training grant Genetic Determinants of Subclinical Atherosclerosis. Dr. Rundek is a co-investigator of several NIH-funded epidemiology grants including the Northern Manhattan Study, Family Study of Carotid Atherosclerosis,  Oral infection, carotid IMT and risk of stroke, Vascular manifestation of primary hyperparathyroidism, and Aortic arch and risk of stroke, all collaborative projects with the Departments of Medicine and Epidemiology at Columbia University, NY and the University of Miami. She is also a co-investigator of the Albert Einstein Aging study in the Bronx, NY.

Dr. Rundek was the Fulbright Scholar and the recipient of the research awards from the Hazel K. Goddess Found to study the relationship between vascular risk factors, subclinical atherosclerosis and stroke in women and the Dr. Gilbert Baum Fund and the American Institute in Ultrasound in Medicine for best clinical application of ultrasound.

Dr. Rundek research work is directed toward the genetic and environmental determinants of stroke and atherosclerosis and use of ultrasound for early detection, intervention and prevention of functional and structural changes of arterial wall in inflammation. Dr. Rundek is also dedicated to promote clinical utility and standards of neurovascular ultrasound.

Dr. Rundek is a member of the American Heart Association, American Academy of Neurology, and American Institute of Ultrasound in Medicine. Dr. Rundek serves on the editorial boards of several professional journals including Neurology, Stroke, Therapy and Journal of CardioMetabolic Syndrome. She is a president elect of the Neurosonology Community Practice of the American Institute of Ultrasound in Medicine.